# LEMTRADA

NDC: 58468-0200
Generic name: ALEMTUZUMAB
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20141118

FDA application: BLA103948

## Active ingredients

- ALEMTUZUMAB: 12 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6236b0bc-82e9-4447-9a78-f57d94770269